Guggenheim Multi-Asset Income ETFFind Ratings Reports
- Last Ratings Update:06/30/2017
- Price as of 06/30/2017 :$20.95
- Net Assets:$1,299.8 Million
- Peer Rank:215 of 266
- Investment Rating:D+
We rate Guggenheim Multi-Asset Income ETF at D+. Negative factors that influence this rating include a high price volatility and short term portfolio management tenure. The fund invests approximately 95% of its assets in stocks and may be considered for investors seeking an Equity Income strategy.
POSITIVES AND RISKS
Total return ranks well below peers over the last three years. The Guggenheim Multi-Asset Income ETF has returned an annual rate of 4.10% since inception. More recently, the fund has generated a total return of 4.93% in the last five years, -2.17% in the last three years, and 14.67% in the last year. How does that compare to other equity funds? In the last five years, it has outperformed 40% of them. It has also outpaced 23% of its competitors on a three year basis and 56% of them over the last year for the period ending 6/30/2017. On a year to date basis, CVY has returned 6.13%.
Downside risk has been below average. CVY has a draw down risk of -33.59%, which is the largest price decline experienced over the last three years. This fund has a three year standard deviation of 11.2%. This fund has had moderate volatility in its monthly performance over the last 36 months. As of 6/30/2017, the fund was trading at a price of $20.95, which is 1.3% below its 52-week high of $21.22 and 1.2% above its 52-week low of $20.71.
Low expense ratio helps performance. On total assets of $1.30 billion, CVY maintains a low expense ratio compared to its Equity Income peers of just 0.65% to cover all operating costs. Brokerage costs for the fund to buy and sell shares are not included in the expense ratio. As CVY is an exchange traded fund, it has no front end or back end load.
The Guggenheim Multi-Asset Income ETF is managed by James R. King at Guggenheim Funds Investment Advisor. This fund is one of 51 Guggenheim Funds Investment Advisor exchange-traded funds launched since 2/25/2004 that we track.